Supplemental Figure 2 from Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations

Supplemental Figure 2. Overall survival from Collection of sample. Survival differences were also analyzed from the time of collection of sample instead of time of diagnosis. Panel A shows survival difference between MF with 0-3 variants and >=4 variants. Panel B shows survival difference between MF patients harboring Ras pathway mutations and those not. Panel C shows the percent survival of patients with ASXL1 mutations in <=60 and >60 age groups as compared to patients without ASXL1 mutation in the same age brackets.